Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

299 results about "Low blood pressures" patented technology

Method and apparatus for non-invasive blood constituent monitoring

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least one predetermined wavelength of light is passed onto or through body tissues such as a finger, earlobe, or scalp, etc. and attenuation of light at that wavelength is detected. Likewise, the change in blood flow is determined by various techniques including optical, pressure, piezo and strain gage methods. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If an additional wavelength of light is used which attenuates light substantially differently by oxyhemoglobin and reduced hemoglobin, then the blood oxygen saturation value, independent of hematocrit may be determined. Further, if an additional wavelength of light is used which greatly attenuates light due to bilirubin (440 nm) or glucose (1060 nm), then the bilirubin or glucose value may also be determined. Also how to determine the hematocrit with a two step DC analysis technique is provided. Then a pulse wave is not required, so this method may be utilized in states of low blood pressure or low blood flow.
Owner:HEMA METRICS

Method and apparatus for non-invasive blood constituent monitoring

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least one predetermined wavelength of light is passed onto or through body tissues such as a finger, earlobe, or scalp, etc. and attenuation of light at that wavelength is detected. Likewise, the change in blood flow is determined by various techniques including optical, pressure, piezo and strain gage methods. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If an additional wavelength of light is used which attenuates light substantially differently by oxyhemoglobin and reduced hemoglobin, then the blood oxygen saturation value, independent of hematocrit may be determined. Further, if an additional wavelength of light is used which greatly attenuates light due to bilirubin (440 nm) or glucose (1060 nm), then the bilirubin or glucose value may also be determined. Also how to determine the hematocrit with a two step DC analysis technique is provided. Then a pulse wave is not required, so this method may be utilized in states of low blood pressure or low blood flow.
Owner:HEMA METRICS

Piezoelectric sensor for measuring pressure fluctuations

The invention relates to a piezoelectric sensor for the improved measurement of mechanical variables such as force, pressure or measurement variables which are derived there from, particularly a PVDF film sensor having an improved sensitivity and temperature stability of the measurement signal for pressure measurements that vary in time and/or space, and for the one- and two-dimensional determination of the position and propagation velocity of pressure fluctuations and pressure waves with a single measurement sensor at a measurement location. A preferred field of application of the invention is the non-invasive, low strain and continuous measurement of the pulse rate and the systolic and diastolic blood pressure of humans and animals by determining the velocity and the signal form of the pulse waves. The object of the invention is to allow the measurements of the blood pressure and the pulse rate, for example even in the case of emergency patients having only a very low blood pressure and patients having circulatory disorders in the extremities, for example patients which have developed diabetes or the “smoker's leg”, by using only one sensor at a measurement location due to the improved measurement sensitivity of the piezoelectric sensor, with the result that the continuous application of a pressurized jacket for continuously measuring and monitoring the blood pressure is not necessary. The present invention solves this problem in that a plurality of parallel strips of a piezoelectric material (1) are associated as a measurement membrane in the pressure sensor according to the invention with a sensor base body (4) in such a manner that the parallel strips are tension preloaded in a one-dimensional and elastic manner in the direction of the piezo dipole orientation and that an empty cavity (5) is provided between the tension preloaded piezoelectric sensor material (1) in the measurement portion and the sensor base body (4), formed by a recess/cutout.
Owner:SECTORCON ING FUR SYST UND SOFTWARETECHN MBH

Cold brewed herbal tea and preparation method thereof

The invention relates to a method for processing a beverage by taking natural plants as raw materials, in particular to a cold brewed herbal tea and a preparation method thereof. The cold brewed herbal tea is processed by using the raw materials such as medical stone, honeysuckle, mulberry leaves, momordica grosvenori, dandelion, tea powder, pollen and the like. The cold brewed herbal tea has the good effects of clearing heat and detoxicating, protecting health, beautifying, treating anemopyretic cold, improving eyesight and removing heat from the liver, relieving cough, relieving summer heat and quenching thirst, relaxing bowel, regulating blood sugar level, reducing blood fat, lowering blood pressure, refreshing, digesting, promoting urination and the like.
Owner:GUANGXI JINSAI HEALTH PRODS

Fruit and vegetable yogurt drink and preparation method thereof

The invention relates to a fruit and vegetable yogurt drink and a preparation method thereof. The method comprises the following steps: selecting excellent apples, cucumbers, carrots, radishes, aloes, mango, pineapple, yangtao, sweet potatoes, tomatoes and milk; cleaning and processing the raw materials; preparing fruit and vegetable juice, and homogenizing and degassing the fruit and vegetable juice; mixing the fruit and vegetable juice with the milk; fermenting, homogenizing and sterilizing; cooling and bulking; checking and warehousing. The fruit and vegetable yogurt drink disclosed by the invention achieves micro-molecularization after being juiced, can be absorbed by a human body more easily, has the characteristics of being pleasant in sweetness and sourness, comprehensive and abundant in nutrition, and appetizing, contains a plurality of natural mineral substances such as dietary fibers, protein, vitamin B2, vitamin C, vitamin E, superoxide dismutase (SOD), carotene, nicotinic acid, calcium, phosphorus, ferrum, potassium, copper and selenium, is an excellent yogurt drink, and also has the effects of stimulating a digestive system and an inner circulation system, reducing blood pressure, preventing cancers, clearing away heat and toxic materials, inducing saliva and slaking thirst, tonifying spleen and reinforcing the stomach, eliminating toxin and beautifying skin, and preventing blurring of image.
Owner:大连润扬科技发展有限公司

Modified release compositions of milnacipran

InactiveUS20060024366A1Reduce incidenceDiminished decreased intensityCoatingsDrageesPalpitationsRash
A once-a-day oral milnacipran modified release formulation has been developed. The formulation comprises an extended release dosage unit (optionally containing the immediate release portion) coated with delayed release coating. The milnacipran composition, when administered orally, first passes through the stomach releasing from zero to less than 10% of the total milnacipran dose and then enters the intestines where drug is released slowly over an extended period of time. The release profile is characterized by a 0.05-4 hours lag time period during which less than 10% of the total milnacipran dose is released followed by a slow or extended release of the remaining drug over a defined period of time. The composition provides in vivo drug plasma levels characterized by Tmax at 4-10 hours and an approximately linear drop-off thereafter and Cmax below 3000 ng / ml, preferably below 2000 ng / ml, and most preferably below 1000 ng / ml. The composition provides a therapeutic effect over approximately 24 hours, when administered to a patient in need, resulting in diminished incidence or decreased intensity of common milnacipran side effects such as sleep disturbance, nausea, vomiting, headache, tremulousness, anxiety, panic attacks, palpitations, urinary retention, orthostatic hypotension, diaphoresis, chest pain, rash, weight gain, back pain, constipation, vertigo, increased sweating, agitation, hot flushes, tremors, fatigue, somnolence, dyspepsia, dysoria, nervousness, dry mouth, abdominal pain, irritability, and insomnia.
Owner:COLLEGIUM PHARMA INC

Device and method for treating respiratory and other diseases

A method and device to prevent and cure body diseases caused by infection factors such as: bacteria, virus, fungi, parasites as well as preventing fat accumulation in body blood vessels, lowering blood pressure, lowering cholesterol level in the blood and destroying body organs cancer cells is done by inhaling vapors of fresh crushed or sliced garlic or vapors of synthetic allicin.
Owner:HIRSHBERG ISRAEL

Compositions and Methods for Treating Hypertension and Inflammation

The present invention relates to pharmaceutical compositions for reducing essential hypertension and systemic inflammation. While many drugs have been found to treat hypertension, the currently available drugs often do not maintain reduced blood pressure at the preferred norm of 115 / 75 mm Hg or less throughout a 24 hour period. The current invention provides compositions comprising at least one hypertensive drug combined with the natural product Coenzyme Q10 (ubiquinone or CoQ10), which synergizes with the antihypertensive drugs to maintain low blood pressure throughout the day and night while generating other positive effects on the risks of cardiovascular disease, renal failure, and stroke. CoQ10 also counteracts some of the side effects of some hypertensive drugs such as tiredness, weakness, and / or liver toxicity. The invention further describes therapeutically effective methods for reducing systemic inflammation in hypertensive mammals comprising treatment with an antihypertensive composition that includes at least one angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and CoQ10 (ubiquinone). The invention metrics for reducing systemic inflammation comprise the reduction of serum levels of high sensitivity C-reactive protein (CRP), Interleukin 6 (IL-6), and / or tumor necrosis factor-alpha (TNF-alpha). These antihypertensive-CoQ10 combinations will synergistically reduce both hypertension and systemic inflammation.
Owner:VILLEPONTEAU BRYANT RICHARD

Non-whole nutrient formula food for coronary heart disease

The present invention belongs to the technical field of medicinal and edible food formulas and new resource foods and specifically provides non-whole nutrient formula food, special whole nutrient formula food or whole nutrient formula food for patients with coronary heart disease to eat. According to the requirements of General Principles of Special Medical Use Formula Foods, in combination with the constitutive characters of the patients with coronary heart disease, and based on the essence of traditional Chinese medicine theory, a variety of medicinal and edible traditional Chinese medicines are reasonably combined; a plurality of types of traditional Chinese medicine extract essences which are extracted by a prehydrolysis SBE technology, oligopeptides extracted by biological enzymolysis, prebiotics, amino acids, carbohydrates, fats with healthcare functions, a plurality of types of vitamins and mineral substances are mixed and then treated by other processes, thereby obtaining the formula food. The formula food can be used as a single nutrient source to meet the nutritional requirements of the patients with coronary heart disease, and also has effects of resisting aging, resisting bacteria and inflammation, calming mind, expanding blood vessels, reducing blood pressure, reducing blood sugar and improving immunity.
Owner:JINSHANMEI BIOTECH

Anti-cancer and blood pressure-lowering noodle and preparation method thereof

The invention discloses an anti-cancer and blood pressure-lowering noodle, which is made of the following raw materials by weight part: 70-80 of wheat, 45-55 of rice, 30-40 of millet, 10-12 of cactus lyophilized powder, 10-12 of rape pollen, 20-30 of bovine bone marrow, 8-10 of osmanthus fragrans, 1-2 of Plantain Herb, 2-3 of Phlomis mongolica, 1-2 of radix isatidis, 4-5 of ginkgo leaves, 3-4 of red claw ginger, 20-24 of radix puerariae, 5-6 of grape seed oil, 1-2 of a noodle additive, and a proper amount of water. The noodle provided by the invention adopts wheat, rice, and millet as the main raw materials. The millet has the effects of benefiting spleen and stomach, nourishing kidney qi, promoting dieresis and the like. The bovine bone marrow can moisten lung, tonify kidney, and enrich marrow. The osmanthus fragrans has the effects of dissipating cold and breaking stagnation, reducing phlegm and relieving cough, improving beauty, and relieving throat, etc. The radix puerariae can enhance the regeneration capacity of liver cells, strengthen the liver detoxification function, promote metabolism, clear heat and help produce saliva, lower blood pressure and blood lipid, prevent and resist cancer, beautify skin and improve appearance, etc. The grape seed oil has the effects of resisting oxidation, lightening color spots, regulating internal secretion, delaying aging, and preventing cancer, etc.
Owner:BAIYUN MILL MINGGUANG

Intelligent ultrasonic physiotherapy device through blood pressure signal control and implementation method thereof

ActiveCN104147713AGood treatment effectUltrasonic output power real-time monitoringUltrasound therapyNumerical controlHigh frequency power
The invention discloses an intelligent ultrasonic physiotherapy device through blood pressure signal control and an implementation method of the device and belongs to the technical field of ultrasonic therapy instruments. The device comprises a system control module, a DDS numerical control frequency source module, a pulse blood pressure acquiring and processing module, a valve module, a high-frequency generator module, an ultrasonic transducer and a frequency monitoring module, wherein the DDS numerical control frequency source module is used for generating ultrasonic frequency square wave signals, the pulse blood pressure acquiring and processing module is used for measuring high blood pressure and low blood pressure of a human body and using the average value of the high blood pressure and the low blood pressure as a parameter for controlling ultrasonic output power, and then pulse signals are acquired and processed by the pulse blood pressure acquiring and processing module so that TTL level control signals synchronous with pulses can be generated. According to the intelligent ultrasonic physiotherapy device through blood pressure signal control and the implementation method of the device, the blood pressure signals of the human body are used as the parameters for controlling the ultrasonic output power, the ultrasonic output power can be adjusted according to the physical conditions of the human body, the ultrasonic therapy application range can be wider, and the therapeutic effect can be better.
Owner:CHONGQING UNIV OF POSTS & TELECOMM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products